Potentiation of Quetiapine Treatment With Lithium or Aripiprazole in Bipolar 1 Nonresponders Patients
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether Bipolar I Disorder refractory treatment
with Quetiapine monotherapy could be better potentiated with Lithium or Aripiprazole. The
investigators hypothesized that Lithium or Aripiprazole would provide similar compliance and
tolerability in maintenance treatment.
Phase:
Phase 4
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Aripiprazole Central Nervous System Depressants Lithium Carbonate Molecular Mechanisms of Pharmacological Action Quetiapine Fumarate